IQ's First Decade: Reflections from IQ Leaders

                   

The IQ Consortium marks its 10th anniversary with a year-long series entitled IQ's First Decade: Reflections from IQ Leaders. In this series, IQ leaders from 2010 to present share their perspectives on the impact brought to the global pharmaceutical industry by IQ initiatives and the value of the IQ consortium’s collaborative environment. 

     
Terry Tougas, PhD Lewis Kinter, PhD    

TERRY TOUGAS, PhD
IQ Chair (2010-2012)

Highly Distinguished Research Fellow
Boehringer Ingelheim (Ret.)

 

LEWIS KINTER, PhD, DABT, FATS
IQ Chair (2012-2014)

Senior Director, Regulatory Toxicology
AstraZeneca (Ret.)

 

 

Margaret Faul, PhD Michael Garvin, PhD    

MARGARET FAUL, PhD
IQ Chair (2021-2023)

Vice President, Drug Product Technologies 
Amgen

 

MICHAEL GARVIN, PharmD
IQ Board of Directors (2014-present)

Senior Director, Regulatory Policy
AstraZeneca